GC
CBST

Guggenheim Capital’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Guggenheim Capital’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-135,910
Closed -$13.7M – 3144
2014
Q4 		$13.7M Sell
135,910
-101,246
-43% -$7.87M 0.03% 728
2014
Q3 		$15.7M Buy
237,156
+8,969
+4% +$589K 0.04% 730
2014
Q2 		$15.9M Sell
228,187
-35,809
-14% -$2.44M 0.04% 738
2014
Q1 		$19.3M Buy
263,996
+22,864
+9% +$1.7M 0.05% 631
2013
Q4 		$16.6M Buy
241,132
+110,590
+85% +$7.16M 0.05% 672
2013
Q3 		$8.29M Buy
130,542
+91,511
+234% +$5.53M 0.03% 905
2013
Q2 		$1.89M Buy
+39,031
New +$1.92M 0.01% 1579

Guggenheim Capital's CBST Position: Q1 2015 in Review

Guggenheim Capital sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 135,910 shares — an estimated $13.7M sold.

Guggenheim Capital first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $19.3M in Q1 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Guggenheim Capital reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Guggenheim Capital sold 135,910 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $13.7M.
  • Guggenheim Capital first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Guggenheim Capital's CUBIST PHARMACEUTICALS INC position peaked at $19.3M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Guggenheim Capital's 13F filing for Q1 2015, filed 15 May 2015.